Drug intelligence / Profile preview

bronopol

Development stage
Unknown
Lead developer
Boots
Modality
Small Molecules
Administration
Topical
01

Overview

Bronopol is a synthetic organic compound with the chemical name 2-bromo-2-nitropropane-1,3-diol. It was first synthesized in 1897 and developed as an antimicrobial preservative by The Boots Company in the early 1960s. Bronopol exhibits broad-spectrum antimicrobial activity and is used primarily as a biocide and preservative in pharmaceuticals, cosmetics, toiletries, household products, and various industrial applications such as water treatment systems and papermills[1][4][6]. Its mechanism of action involves catalyzing the oxidation of thiol groups (such as cysteine) within bacterial cells under aerobic conditions. This process generates reactive oxygen species like superoxide and peroxide that exert bactericidal effects by inhibiting enzyme function and suppressing cellular respiration[1][5][8]. Bronopol is particularly effective against Gram-negative bacteria including Pseudomonas species but has limited antifungal activity[6]. Due to concerns about nitrosamine formation under certain conditions (alkaline pH or elevated temperatures), its use in personal care products has declined since the late 1980s[4].

Other names
2-bromo-2-nitropropane-1,3-diol2-bromo-2-nitro-1,3-propanediol

Beyond the preview

Go deeper on bronopol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on bronopol.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call